Clinical Trials on Sexually Transmitted Infections

Total 99352 results

University of California, San Francisco
Bill and Melinda Gates Foundation; Medical Research Council, South Africa; Ibis... and other collaborators

Withdrawn

Effectiveness of the Diaphragm for HIV Prevention

HIV Infection

South Africa, Zimbabwe
St Stephens Aids Trust

Completed

Atripla to Raltegravir Switch Study for CNS Toxicity (SSAT036)

HIV Infection

United Kingdom
Family AIDS Caring Trust
World Health Organization; Canadian International Development Agency

Unknown

Effects of Facility-based Mother Support Groups on Prevention of mother-to Child Transmission Outcomes in Zimbabwe (EPAZ)

HIV Infection

Zimbabwe
ApoPharma

Completed

Antiretroviral Activity and Pharmacokinetics of Deferiprone in Healthy Volunteers and Asymptomatic HIV-infected Subjects

HIV Infection

South Africa
Tibotec Pharmaceuticals, Ireland

Completed

An Open Label Trial of TMC114/RTV in HIV-1 Infected, Treatment-experienced Subjects.

HIV Infection

United States, Australia, France, United Kingdom, Germany, Spain, Belgium, Portugal, Canada, Argentina, Brazil, Austria, Hungary
St Stephens Aids Trust

Unknown

Hydroxychloroquine for Discordant CD4 Responders on Highly Active Antiretroviral Therapy (HAART) (SSAT039)

HIV Infection

United Kingdom
Medecins Sans Frontieres, Netherlands

Completed

Comparison of HIV Testing Algorithms

HIV Infection

Ethiopia
Columbia University
National Institute of Mental Health (NIMH)

Completed

Using Multimedia Technologies to Disseminate an HIV Prevention

HIV Infection

United States
Hospitales Universitarios Virgen del Rocío

Completed

Darunavir Levels, Virological Efficacy, Proviral ADN and Resistances in Patients on Darunavir/Ritonavir Monotherapy (MonDar)

HIV-infection

Spain
Pfizer
Altmarc Inc.

Completed

Drug Use Investigation On Zithromac (Azithromycin) In HIV Patients

HIV Infection
International AIDS Vaccine Initiative
University of Rochester; Aaron Diamond AIDS Research Center

Completed

Safety and Immunogenicity of a Plasmid HIV Vaccine in HIV Uninfected Adults (C001)

HIV Infection

United States
Genetic Immunity
IRCCS Policlinico S. Matteo; ViroStatics srl

Completed

Antiretroviral-Sparing Concept With HIV-specific T Cell Precursors With High Proliferative Capacity (PHPC) (PHPC-02)

HIV Infection

Italy
Centre For International Health
Makerere University

Completed

Male Involvement in Antenatal Care and the Prevention Programme of Mother-to-child Transmission of HIV in Uganda (InvolvMaleUg)

HIV Infection

Uganda
University of British Columbia
National Institute on Drug Abuse (NIDA)

Completed

Use of Incentives to Engage Drug Users in HIV Therapy (Incentives-1)

HIV Infection

Canada
International Partnership for Microbicides, Inc.

Withdrawn

A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa

HIV Infections

South Africa, Kenya, Malawi
St Stephens Aids Trust

Completed

PK Switch Efavirenz to Maraviroc in Patients Initially Suppressed on an Efavirenz-containing Regimen (SSAT033)

HIV Infection

United Kingdom
University of Minnesota
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Interleukin-2 Plus Antiretroviral Therapy for HIV-Infected Patients With Low CD4+ Counts (SILCAAT Study) (SILCAAT)

HIV Infection

United States
Avexa

Completed

A Long Term, Safety Study of Apricitabine in HIV-infected Subjects

HIV Infection

Australia
VIRxSYS Corporation

Active, not recruiting

Safety and Efficacy of T Cell Genetic Immunotherapy for HIV

HIV Infection

United States
GlaxoSmithKline

Terminated

Study Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5/X4-Tropic Treatment-Experienced HIV-Infected Subjects

HIV Infection

United States, Belgium
Istituto Superiore di Sanità

Completed

Observational Study of the Therapeutic Study of Recombinant HIV-1 TAT (ISS OBS T-001)

HIV Infection

Italy
French National Agency for Research on AIDS and...

Completed

Residual Replication of HIV-1 in the Gut Associated Lymphoid Tissue (GALT) of Patients on Highly Active Antiretroviral Therapy (HAART): the ANRS EP 44 Study (EP 44)

HIV Infection

France
Georgetown University
Advanced Biotherapy, Inc.

Completed

Safety and Efficacy Study of Etanercept (Enbrel) on the Response Rate of HIV-infected Subjects

HIV Infection

United States
University of Oklahoma
Abbott

Terminated

Pharmacokinetic Study of Two HIV Protease Inhibitors in Patients

HIV Infection

United States
GlaxoSmithKline

Completed

Pharmacokinetic Study Of EPZICOM Tablet

HIV Infection

Japan
Abbott

Completed

Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Therapy to Treat HIV in Antiretroviral Naїve Patients (MONARK)

HIV Infection
Arribas, Jose R., M.D.
Abbott; Pulido, Federico, M.D.

Completed

"OK 2004 Study" (Only Kaletra 2004 Study): Study to Evaluate Suspending Nucleosides From Triple-Drug Therapy in HIV Subjects

HIV Infection

Spain
National Institute of Allergy and Infectious Diseases...

Completed

Intermittent Versus Continuous Medication in the Treatment of HIV

HIV Infection

United States
French National Agency for Research on AIDS and...

Completed

Feasibility Study of a Once Daily Antiretroviral Regimen in Vietnam (ANRS 1210 VIETAR)

HIV Infection

Vietnam
The University of Hong Kong

Completed

To Compare the Strategies of Universal Antibiotic Prophylaxis Versus Screen-and-treat in Reducing Infective Complications and Re-infection in Women Who Undergo Termination of Pregnancy

Sexually Transmitted Infections | Induced Abortion | Postaboral Pelvic Inflammatory Disease

China
Centers for Disease Control and Prevention
University of Alabama at Birmingham

Completed

Nucleic Acid Amplification Tests (NAATs) for the Diagnosis of Pharyngeal and Rectal Chlamydia and Gonorrhea Infections

Gonorrhea | Chlamydia Infections

United States
Serum Institute of India Pvt. Ltd.
Bill and Melinda Gates Foundation

Not yet recruiting

Clinical Study to Evaluate SIIPL qHPV Vaccine (CERVAVAC®) in Women Living With HIV Aged 15-25 Years

Human Papillomavirus Infection

Kenya, Mozambique, South Africa
National Cancer Institute (NCI)

Active, not recruiting

Single-Dose HPV Vaccination for the Prevention of Cervical Cancer in Young Adult Women in Costa Rica, The PRISMA ESCUDDO Trial (PRISMA)

Cervical Carcinoma | Human Papillomavirus Infection

Costa Rica
Fujian Maternity and Child Health Hospital

Active, not recruiting

Characteristics of Vaginal and Intestinal Microbiota and Cervical HPV Infection

HPV Infection | Intestinal Microbiota | Vaginal Microbiota

China
Sidney Kimmel Comprehensive Cancer Center at Johns...

Not yet recruiting

Assessing Jet Administration of pBI-11 for the Treatment of Patients With HPV16/18+

HPV Infection
Queen Mary University of London
National Cancer Institute (NCI)

Recruiting

HPV Self-testing in Transgender Individuals (Self-TI)

HPV Infection

United Kingdom
Boston Medical Center
Merck Sharp & Dohme LLC

Recruiting

An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen

HPV Infection

United States
Assiut University

Completed

Serum Galectin-3 as a Marker of Human Papillomavirus Infection

Human Papillomavirus Infection

Egypt
Centro de Investigaciones Medicas y Ensayos Clinicos...
CALOX Laboratories; Bioanalisis

Unknown

Betaglucin 0.2% Versus Imiquimod 5% in Treatment of Ano-genital Warts: Combined Results From Triple Blind Controlled Study (BETAGENWART)

Genital Wart Virus Infection

Nicaragua
Eva Bonfill

Recruiting

Safety, Tolerance and Antiretroviral Activity of Dasatinib: a Pilot Clinical Trial in Patients With Recent HIV-1 Infection (DASAHIVCURE)

Recent HIV-1 Infection

Spain
NOWDiagnostics, Inc.

Completed

NOWDx Test for the Diagnosis of Syphilis

Syphilis Infection | Treponema Pallidum Infection

United States
Gilead Sciences

Active, not recruiting

Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With an Optimized Background Regimen (OBR) in Heavily Treatment Experienced Participants Living With HIV-1 Infection With Multidrug Resistance (CAPELLA)

HIV-1-infection

United States, Spain, France, Taiwan, Japan, Thailand, Dominican Republic, Germany, Canada, Italy, South Africa
Shanghai Public Health Clinical Center
Yunnan AIDS Care Center; Xixi Hospital of Hangzhou

Active, not recruiting

Switching From TDF-based Antiretroviral Therapy Regimens to B/F/TAF in Virally Suppressed Adults With HIV-1 Infection

HIV-1-infection

China
Fundacion SEIMC-GESIDA
Abbott

Completed

Treatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receiving ART Monotherapy With Lopinavir/r (PEKARI)

HIV Infections | HIV/HCV Co-infection

Spain
Hospitales Universitarios Virgen del Rocío
Instituto de Biomedicina de Sevilla

Enrolling by invitation

Seville Cohort of People at Substantial Risk for HIV Infection on Pre-exposure Prophylaxis (SeVIHPrEP)

Hepatitis, Viral, Human | HIV Infection Primary | Sexually Transmitted Infections, Excluding HIV and Hepatitis

Spain
Assistance Publique Hopitaux De Marseille

Completed

Significance of the High-risk Hpv Viral Load

HPV Infections

France
ANRS, Emerging Infectious Diseases

Not yet recruiting

Role of the IL33/Amphiregulin Pathway as a Potential Therapeutic Target in HIV Infection

HIV I Infection
McGill University Health Centre/Research Institute...

Completed

Metformin Immunotherapy in HIV Infection

HIV Infection

Canada
National Institute of Allergy and Infectious Diseases...
GlaxoSmithKline; Bill and Melinda Gates Foundation; Medical Research Council; Sanofi... and other collaborators

Completed

A Safety and Immune Response Study of 2 Experimental HIV Vaccines

HIV Infection

South Africa
National Institute of Allergy and Infectious Diseases...
AIDS Clinical Trials Group; HIV Prevention Trials Network

Completed

Evaluating the Safety and Tolerability of Antiretroviral Drug Regimens Used as Pre-Exposure Prophylaxis to Prevent HIV Infection in At-Risk Men Who Have Sex With Men and in At-Risk Women

HIV Infection

United States, Puerto Rico

Clinical Trials on Sexually Transmitted Infections

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Trinidad & Tobago

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations